Tech Company Financing Transactions
BridgeBio Pharma Funding Round
BridgeBio Pharma closed a $300 million funding round on 6/30/2025. Backers included Blue Owl Capital.
Transaction Overview
Company Name
Announced On
6/30/2025
Transaction Type
Venture Equity
Amount
$300,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
421 Kipling St.
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
BridgeBio Pharma (Nasdaq: BBIO) is a collection of individuals focused on discovering and developing drugs for patients with grievous genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Kumar
Browse more venture capital transactions:
Prev: 6/30/2025: AvenCell Therapeutics venture capital transaction
Next: 6/30/2025: Campfire venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs